Clinical Trials in Salt Lake City

Showing 4181-4200 of 16,694 trials

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.

Quanta Therapeutics240 participantsStarted May 2024

Grand Rapids, Michigan, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

Active Not Recruiting< 1 mile

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

The purpose of the PaTH Network IPF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients with Idiopathic Pulmonary Fibrosis, providers, and other stakeholders.

Idiopathic Pulmonary Fibrosis

University of Pittsburgh1,000 participantsStarted Mar 2015

Baltimore, Maryland, United States • Hershey, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 17.5 miles

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

NCT05391022

Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies

Advanced MalignanciesSolid TumorHematological Malignancy

Constellation Pharmaceuticals35 participantsStarted Jul 2021

Canton, Ohio, United States • Gettysburg, Pennsylvania, United States • West Valley City, Utah, United States +7 more locations

QTX3046 in Patients With KRAS G12D Mutations

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Find Trials by Condition in Salt Lake City

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

Diet and Fasting for Long COVID

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

First-in-human Study of MRT-6160 in Healthy Subjects

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Open-Label Surufatinib in European Patients With NET

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Ceribell Delirium Data Collection Study